Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

CIOMS in Pharmacovigilance: Inspection Expectations and Expedited Safety Reporting Governance 2026

This article explains how regulators assess the Pharmacovigilance System Master File during inspections, where governance gaps create audit findings, and why clear accountability, traceability, and inspection readiness determine long-term regulatory confidence.
  • Blog, GxP
Pharmacovigilance professional reviewing safety documents to ensure data consistency in safety reports and traceable regulatory safety communication.

PBRER in Pharmacovigilance: Inspection Expectations and Benefit–Risk Governance in 2026

An inspection-driven overview explaining how regulators assess benefit–risk narratives in PBRERs, where governance gaps trigger repeat findings, and how structured oversight across reporting cycles strengthens compliance and regulatory confidence in pharmacovigilance systems.
  • Blog, GxP
Quality assurance team reviewing safety data as part of benefit risk assessment lifecycle and regulatory benefit–risk oversight.

DSUR in Pharmacovigilance: Inspection Expectations and 2026 Downloadable PDF

This article explains how regulators assess DSURs during clinical development, focusing on safety governance, benefit–risk assessment, and data consistency across trials. It highlights common inspection findings and shows how structured oversight reduces regulatory risk and inspection escalation.
  • Blog, GxP
Illustration showing sponsor safety governance, safety data integration across trials, and benefit–risk assessment during development aligned with developmental safety update report compliance.

PSMF in pharmacovigilance: Inspection Expectations, Governance, and Compliance Focus in 2026

This article explains how regulators assess the Pharmacovigilance System Master File during inspections, where governance gaps create audit findings, and why clear accountability, traceability, and inspection readiness determine long-term regulatory confidence.
  • Blog
Structured documentation and clear audit trails support pharmacovigilance system master file governance and inspection readiness.

PSUR in Pharmacovigilance: Inspection Expectations and Regulatory Focus in 2026

This article explains how PSURs support regulatory assessment through structured benefit–risk evaluation, safety data integration, and inspection readiness, helping organizations maintain consistent safety reasoning and meet evolving regulatory expectations across post-marketing reporting cycles.
  • Blog
PSUR in Pharmacovigilance

ISO 9001 2026: What You Need to Know

The ISO 9001 2026 revision is underway, introducing modern elements such as digital systems, ESG principles, and enhanced risk and resilience guidance. This article provides an overview of the upcoming changes and what organizations should expect.
  • ISO 9001, Quality Management System
Achieve operational excellence by building a strong foundation of equipment qualification documentation and protocols.

Why CAPA Effectiveness Checks Are More Important Than Ever in Pharma

The pharmaceutical industry is under growing scrutiny from regulators when it comes to CAPA effectiveness checks. This blog explores how to improve root cause analysis, ensure closed-loop CAPA systems, and avoid repeat findings in GMP audits.
  • Audit and Inspection, Quality Management System
scientist conducting an audit of the company

IVDR Transition: A Real Test for QA Teams

The IVDR transition is reshaping the EU diagnostics industry. This post explores how QA teams can handle real challenges during implementation—especially for Class B and C IVDs—while staying compliant with UDI, PMS, and performance evaluation requirements.
  • MD/IVD Regulations, Medical Devices, Technical Documentation
Doctor with digital medical device

Medical Device Clinical Trials – What You Need to Know in 2025

Understanding how clinical trials for medical devices are designed, conducted, and evaluated is critical in a highly regulated market. Here’s a clear, current, and professional look into the world of medical device clinical trials in 2025.
  • MD/IVD Regulations, Medical Devices
Female doctor looking at transparent tablet with medical digital diagnostic screen

Working Standards in Pharma: Ensuring Quality and Compliance

Discover how working standards uphold quality, safety, and regulatory compliance in the pharmaceutical industry. Explore key components and best practices.
  • GxP, Quality Management System
The lifecycle of a working standard involves several stages